These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 22783049)
1. Intestinal alkaline phosphatase in the colonic mucosa of children with inflammatory bowel disease. Molnár K; Vannay A; Szebeni B; Bánki NF; Sziksz E; Cseh A; Győrffy H; Lakatos PL; Papp M; Arató A; Veres G World J Gastroenterol; 2012 Jul; 18(25):3254-9. PubMed ID: 22783049 [TBL] [Abstract][Full Text] [Related]
2. Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease. Szebeni B; Veres G; Dezsõfi A; Rusai K; Vannay A; Mraz M; Majorova E; Arató A Clin Exp Immunol; 2008 Jan; 151(1):34-41. PubMed ID: 17991289 [TBL] [Abstract][Full Text] [Related]
3. Role of alkaline phosphatase in colitis in man and rats. Tuin A; Poelstra K; de Jager-Krikken A; Bok L; Raaben W; Velders MP; Dijkstra G Gut; 2009 Mar; 58(3):379-87. PubMed ID: 18852260 [TBL] [Abstract][Full Text] [Related]
4. Lower expression of endogenous intestinal alkaline phosphatase may predict worse prognosis in patients with Crohn's disease. Park SY; Kim JY; Lee SM; Chung JO; Seo JH; Kim S; Kim DH; Park CH; Ju JK; Joo YE; Lee JH; Kim HS; Choi SK; Rew JS BMC Gastroenterol; 2018 Dec; 18(1):188. PubMed ID: 30558547 [TBL] [Abstract][Full Text] [Related]
5. Decreased mucosal expression of intestinal alkaline phosphatase in children with coeliac disease. Molnár K; Vannay A; Sziksz E; Bánki NF; Győrffy H; Arató A; Dezsőfi A; Veres G Virchows Arch; 2012 Feb; 460(2):157-61. PubMed ID: 22262031 [TBL] [Abstract][Full Text] [Related]
6. Intestinal alpha-defensin expression in pediatric inflammatory bowel disease. Zilbauer M; Jenke A; Wenzel G; Goedde D; Postberg J; Phillips AD; Lucas M; Noble-Jamieson G; Torrente F; Salvestrini C; Heuschkel R; Wirth S Inflamm Bowel Dis; 2011 Oct; 17(10):2076-86. PubMed ID: 21910169 [TBL] [Abstract][Full Text] [Related]
7. G protein-coupled receptor 55 (GPR55) expresses differently in patients with Crohn's disease and ulcerative colitis. Włodarczyk M; Sobolewska-Włodarczyk A; Cygankiewicz AI; Jacenik D; Krajewska WM; Stec-Michalska K; Piechota-Polańczyk A; Wiśniewska-Jarosińska M; Fichna J Scand J Gastroenterol; 2017; 52(6-7):711-715. PubMed ID: 28272905 [TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor γ 2 mutation may cause a subset of ulcerative colitis. Aoyagi Y; Nagata S; Kudo T; Fujii T; Wada M; Chiba Y; Ohtsuka Y; Yamashiro Y; Shimizu T; Ohkusa T Pediatr Int; 2010 Oct; 52(5):729-34. PubMed ID: 20591056 [TBL] [Abstract][Full Text] [Related]
9. Intestinal interleukin-8 concentration and gene expression in inflammatory bowel disease. Nielsen OH; Rüdiger N; Gaustadnes M; Horn T Scand J Gastroenterol; 1997 Oct; 32(10):1028-34. PubMed ID: 9361176 [TBL] [Abstract][Full Text] [Related]
10. Significance of intestinal alkaline phosphatase in predicting histological activity of pediatric inflammatory bowel disease. Ateş BB; Talim B; Gülşen HH; Demir H; Karaismailoğlu E; Özen H; Saltık-Temizel İN Turk J Pediatr; 2022; 64(6):1068-1076. PubMed ID: 36583889 [TBL] [Abstract][Full Text] [Related]
11. ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides. Hu X; Deng J; Yu T; Chen S; Ge Y; Zhou Z; Guo Y; Ying H; Zhai Q; Chen Y; Yuan F; Niu Y; Shu W; Chen H; Ma C; Liu Z; Guo F Gastroenterology; 2019 Mar; 156(4):1098-1111. PubMed ID: 30452920 [TBL] [Abstract][Full Text] [Related]
12. Imbalance of the interleukin 1 system in colonic mucosa--association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2. Andus T; Daig R; Vogl D; Aschenbrenner E; Lock G; Hollerbach S; Köllinger M; Schölmerich J; Gross V Gut; 1997 Nov; 41(5):651-7. PubMed ID: 9414973 [TBL] [Abstract][Full Text] [Related]
13. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5. Weersma RK; Zhou L; Nolte IM; van der Steege G; van Dullemen HM; Oosterom E; Bok L; Peppelenbosch MP; Faber KN; Kleibeuker JH; Dijkstra G Inflamm Bowel Dis; 2008 Dec; 14(12):1615-22. PubMed ID: 18668679 [TBL] [Abstract][Full Text] [Related]
14. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium. Pedersen G Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335 [TBL] [Abstract][Full Text] [Related]
15. Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways. Souza HS; Tortori CJ; Castelo-Branco MT; Carvalho AT; Margallo VS; Delgado CF; Dines I; Elia CC Int J Colorectal Dis; 2005 May; 20(3):277-86. PubMed ID: 15503066 [TBL] [Abstract][Full Text] [Related]